查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929596

疝气修补器市场按类型、材料类型、产品类型、应用、最终用户、分销管道划分，全球预测（2026-2032年）

Hernia Tacker Market by Type, Material Type, Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年疝气固定器市场价值为 1.6221 亿美元，预计到 2026 年将成长至 1.7727 亿美元，预计到 2032 年将达到 2.5284 亿美元，复合年增长率为 6.54%。

关键市场统计数据
基准年 2025 1.6221亿美元
预计年份：2026年 1.7727亿美元
预测年份 2032 2.5284亿美元
复合年增长率 (%) 6.54%

本文简要概述了疝气修补器在现代外科环境中的临床效用、采购考量和策略意义。

外科固定器械的演进需要高层进行全面考量，平衡并整合临床效用、采购实际情况和供应链韧性。本文概述了疝钉的现状，重点介绍了疝钉在现代疝气修补术流程中的作用、其应用的手术场景，以及临床结果与器械人体工学和材质选择之间的关係。深入分析后可知，疝钉并非单一用途、一刀切的器械，而是可配置的工具，其材质成分、一次性使用方式以及与微创技术的兼容性各不相同。

临床实务、材料和采购方式的快速变化正在重塑手术团队和供应商对器械性能和长期疗效的优先排序。

疝气修补器领域正经历一场变革，其驱动力来自不断发展的临床实践、材料科学的进步以及医疗服务模式的转变。过去几年，微创技术和加速復健通讯协定的普及推动了对能够简化固定流程、缩短手术时间和减少术后併发症的器械的需求。同时，聚合物配方和钛合金的创新也拓展了设计选择，使得更轻、生物相容性更好的固定元件成为可能，从而满足了外科医生的人体工学偏好。

2025年关税趋势的变化正在重塑外科器械相关人员的筹资策略，加剧了对供应链韧性的需求。

2025年关税调整和贸易政策发展的累积影响，为製造商、经销商和医疗系统采购团队带来了额外的营运复杂性。关税结构的变化将影响原料的采购选择，尤其是含有钛等高价值金属和特殊医用级聚合物的医疗设备。因此，供应链负责人必须在成本压力与确保器材品质稳定和符合监管要求的临床需求之间取得平衡。

以细分市场主导的洞察，将临床应用案例、产品形式、通路和材料选择与可操作的商业化选择联繫起来。

对市场区隔的深入理解能够指导产品设计、市场进入策略和临床合作策略。按应用领域划分，我们检视切口疝气、腹股沟疝气、脐疝气和腹疝气。每种应用领域都有其自身的固定挑战和临床优先事项，这些因素会影响器械的选择和外科医生的偏好。依产品类型划分，我们分析一次性器械和可重复使用器械的市场，并根据单位经济效益、消毒基础设施和感染控制通讯协定，建构不同的价值提案。按最终用户划分，我们分析门诊手术中心、诊所和医院的市场。各机构的手术量、采购权限及医疗服务模式的差异会影响器材的采用路径和物流。

采购、临床实践和基础设施的区域差异决定了世界各地采取不同的策略方法。

区域趋势影响着监管路径、采购行为和临床实践模式，为医疗设备製造商和供应商带来不同的机会和挑战。美洲市场通常高度重视高效的采购週期、门诊手术中心的高利用率以及能够缩短手术时间和减少术后併发症的证据。欧洲、中东和非洲地区的法规结构和医院采购流程各不相同，因此在地化的临床数据和有针对性的报销策略显得尤为重要。在亚太地区，微创技术的快速普及与医院基础设施的多样性并存，根据该地区的临床经济状况，既需要经济实惠的一次性产品，也需要耐用的可重复使用系统。

竞争分析应着重于临床支援、产品差异化和通路效率，以此作为永续优势的来源。

疝气修补器材领域的竞争动态由临床证据、技术差异化和商业性可行性三者共同驱动。主要企业凭藉器材的人体工学设计、材料科学以及对外科团队的临床支援等优势展开竞争。有些企业强调一次性使用的便利性，以满足感染控制和手术量的需求；而有些企业则专注于可重复使用的平台，以最大限度地降低高流量中心的单例手术成本。此外，外科医生培训计画、手术记录和快速分销网络等配套服务也常常带来竞争优势。

实际可行的策略性倡议，旨在经营团队主管提高医疗设备产品组合的临床应用率、增强供应链韧性并实现价值驱动的商业化。

产业领导者应优先采取一系列战术性和策略倡议，将洞察转化为可衡量的成果。首先，根据每项手术的具体需求（例如切口、鼠蹊部、脐部和腹壁修復），将材料和产品类型的选择与临床路径相匹配。其次，透过有针对性的真实世界研究和註册登记，加强证据基础，以证明手术效率和以患者为中心的疗效，从而支持医疗系统采用和核准。第三，投资于灵活的分销模式，将与关键客户的直接互动与分销商伙伴关係相结合，以确保覆盖医院、门诊手术中心和诊所。

采用稳健的混合调查方法，整合临床医师见解、法规环境和供应链分析，以得出可操作的结论。

本分析的调查方法融合了定性和定量方法，旨在全面了解整个疝气修补器市场。主要研究包括对外科医生、采购主管和分销合作伙伴进行结构化访谈，以了解器械性能的考量因素、推广应用障碍和培训需求。次要研究则整合了同侪审查的临床文献、监管指南和公共采购框架，以分析临床趋势和政策影响。

整合关键的临床、商业性和供应链挑战，从而为疝气修补器市场的永续领导地位指明方向

总之，疝气修补器领域正处于一个转折点，不断发展的临床实践、材料创新和重塑的商业模式在此交汇融合。这些器械的未来取决于製造商如何有效地回应外科医生的偏好，如何使材料和产品类型与临床应用案例相匹配，以及如何投资于能够切实提高手术效率和改善患者预后的证据。供应链的韧性和适应性分销策略也将发挥至关重要的作用，尤其是在贸易政策变化影响材料采购和成本动态的情况下。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 疝气手术市场（按类型划分）

  • 不吸水钉
  • 吸收性塔克
  • 免洗钉枪
  • 可重复使用的标记器

9. 依材料类型分類的疝气修补器市场

  • 聚合物
  • 钛

第十章 疝气修补器市场（依产品类型划分）

  • 一次性
  • 可重复使用的

第十一章 疝气修补器市场按应用领域划分

  • 切口疝
  • 腹股沟疝气
  • 脐疝气
  • 腹壁疝

第十二章 疝气修补器市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 疝气修补器市场依通路划分

  • 直销
  • 经销商

第十四章 疝气修补器市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 疝气塔克市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国疝气塔克市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国疝气修补术市场

第十八章：中国的疝气手术市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Atrium Medical Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cook Medical LLC
  • Ethicon, Inc.
  • Herniamesh Srl
  • LifeCell Corporation
  • Medtronic plc
  • Via Surgical Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-0A380695183F

The Hernia Tacker Market was valued at USD 162.21 million in 2025 and is projected to grow to USD 177.27 million in 2026, with a CAGR of 6.54%, reaching USD 252.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 162.21 million
Estimated Year [2026] USD 177.27 million
Forecast Year [2032] USD 252.84 million
CAGR (%) 6.54%

Concise framing of clinical utility, procurement considerations, and strategic relevance of hernia tackers across contemporary surgical environments

The evolution of surgical fixation devices requires an executive-level synthesis that balances clinical utility, procurement realities, and supply chain resilience. This introduction frames the hernia tacker landscape by outlining the device's role in modern hernia repair workflows, the procedural contexts in which it is adopted, and the intersection of clinical outcomes with device ergonomics and material choices. Closer inspection reveals that the hernia tacker is not a single-purpose commodity but a configurable tool that varies by material composition, disposability, and compatibility with minimally invasive techniques.

Transitioning from description to strategic relevance, the introduction emphasizes how stakeholders across hospitals, ambulatory surgical centers, and clinics evaluate these devices through lenses of procedure throughput, surgeon preference, and cost-of-care. It also highlights the importance of product training and clinical evidence in shaping adoption curves. Finally, the introduction establishes the analytical approach used throughout the report: integrating clinical practice trends, procurement patterns, and regulatory dynamics to present a cohesive view that supports senior leaders in making informed, actionable choices.

Rapid clinical, material, and procurement shifts are reconfiguring how surgical teams and suppliers prioritize device performance and long-term outcomes

The hernia tacker landscape is experiencing transformative shifts driven by clinical practice evolution, material science advances, and changing care delivery models. Over the past several years, minimally invasive techniques and enhanced recovery protocols have increased demand for devices that streamline fixation while reducing operative time and postoperative complications. Concurrently, innovations in polymer formulations and titanium alloys have expanded design possibilities, enabling lighter, more biocompatible fixation elements that align with surgeons' ergonomic preferences.

In addition to technological change, procurement and distribution models are shifting toward value-based purchasing and broader use of ambulatory surgical centers. These dynamics are redefining how device suppliers engage with health systems and surgical teams, prompting manufacturers to invest in outcome-focused clinical evidence and training programs. Regulatory focus on device traceability and post-market surveillance is also intensifying, which in turn affects product development timelines and labeling strategies. Taken together, these trends signal a market that is moving from commodity-driven transactions toward collaborative partnerships centered on clinical outcomes, cost-efficiency, and long-term device performance.

Evolving tariff dynamics in 2025 are intensifying supply chain resilience needs and reshaping procurement strategies for surgical device stakeholders

The cumulative effect of tariff adjustments and trade policy developments in 2025 has introduced additional layers of operational complexity for manufacturers, distributors, and health system procurement teams. Shifts in tariff structures affect raw material sourcing choices, particularly for devices that incorporate high-value metals like titanium or specialized medical-grade polymers. As a result, supply chain planners must now balance cost pressures against the clinical imperative for consistent device quality and regulatory compliance.

These changes have also reinforced the importance of diversified sourcing strategies and localized manufacturing where feasible. Organizations that previously relied on single-region supply chains now evaluate dual-sourcing options or regional inventory buffering to mitigate exposure to trade disruptions. Meanwhile, procurement teams are renegotiating supplier agreements to include contingencies for tariff-driven cost adjustments and to preserve long-term clinical relationships. Ultimately, the tariff environment of 2025 has sharpened the focus on supply chain resilience, regulatory alignment, and transparent cost modeling as prerequisites for sustained device availability and predictable procurement budgeting.

Segment-driven insight that connects clinical use cases, product form factors, distribution pathways, and material selection to practical commercialization choices

A nuanced understanding of segmentation informs product design, market access tactics, and clinical engagement strategies. Based on Application, market is studied across Incisional Hernia, Inguinal Hernia, Umbilical Hernia, and Ventral Hernia, and each application presents distinct fixation challenges and clinical priorities that influence device selection and surgeon preference. Based on Product Type, market is studied across Disposable and Reusable options, creating divergent value propositions tied to unit economics, sterilization infrastructure, and infection control protocols. Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals, which differ in procedural volume, purchasing authority, and care delivery models, affecting adoption pathways and logistics.

Based on Distribution Channel, market is studied across Direct Sales and Distributor frameworks, which determine the nature of customer relationships, post-sale support, and training programs that accompany device deployment. Based on Material Type, market is studied across Polymer and Titanium solutions, and material selection drives trade-offs among cost, radiopacity, biocompatibility, and long-term implant behavior. Integrating these segmentation perspectives enables stakeholders to map product attributes to clinical use cases, prioritize investment in evidence generation, and align commercial models with the operational realities of distinct care settings.

Geographic distinctions in procurement, clinical practice, and infrastructure that determine differentiated strategic approaches across global regions

Regional dynamics influence regulatory pathways, purchasing behaviors, and clinical practice patterns, creating differentiated opportunities and constraints for device manufacturers and suppliers. Americas markets often emphasize streamlined procurement cycles, higher utilization of ambulatory surgical centers, and a strong focus on evidence demonstrating reductions in procedure time and post-operative complications. Europe, Middle East & Africa exhibit heterogeneity in regulatory frameworks and hospital procurement processes, which elevates the importance of localized clinical data and targeted reimbursement strategies. Asia-Pacific demonstrates rapid adoption of minimally invasive techniques alongside varied hospital infrastructure, creating demand for both cost-effective disposable options and durable reusable systems depending on local clinical economics.

These regional profiles inform go-to-market strategies, distribution footprint planning, and clinical education investments. For instance, engagement that prioritizes ambulatory surgical center workflows will resonate more strongly in markets that are shifting procedures out of inpatient settings, whereas regions with centralized hospital procurement require deeper health economics and outcomes research to support adoption. By aligning product positioning with the specific characteristics of the Americas, Europe, Middle East & Africa, and Asia-Pacific, organizations can better allocate resources and design regionally appropriate value propositions.

Competitive landscape analysis emphasizing clinical support, product differentiation, and channel effectiveness as drivers of sustainable advantage

Competitive dynamics in the hernia tacker space are shaped by a blend of clinical evidence, technology differentiation, and commercial execution. Leading companies compete on the merits of device ergonomics, material science, and the depth of clinical support they provide to surgical teams. Some firms emphasize disposability and single-use convenience to meet infection control and throughput demands, while others focus on reusable platforms that minimize per-case costs in high-volume centers. In many cases, competitive advantage derives from complementary services, including surgeon training programs, procedural documentation, and responsive distribution networks.

In addition, intellectual property surrounding novel fixation mechanisms and coating technologies plays a role in defining competitive boundaries. Companies that invest early in post-market surveillance and long-term outcomes studies tend to build stronger clinical credibility, which supports premium positioning and inclusion in standardized hospital formularies. The interplay of pricing strategies, channel partnerships, and targeted clinical engagement ultimately determines which companies can sustain growth while meeting increasingly stringent regulatory and procurement expectations.

Practical and strategic actions for executives to strengthen clinical adoption, supply chain resilience, and value-focused commercialization in device portfolios

Industry leaders should prioritize a set of tactical and strategic initiatives to convert insights into measurable outcomes. First, align product portfolios to clinical pathways by matching material and product type decisions to the specific procedural demands of incisional, inguinal, umbilical, and ventral repairs. Second, strengthen the evidence base through targeted real-world studies and registries that demonstrate comparative procedural efficiency and patient-centered outcomes, thereby supporting health system adoption and procurement approvals. Third, invest in flexible distribution models that combine direct engagement with key accounts and distributor partnerships to ensure coverage across hospitals, ambulatory surgical centers, and clinics.

Additionally, build supply chain resilience through diversified sourcing and regional inventory strategies to mitigate tariff and trade volatility. Expand surgeon training and implementation support to reduce the learning curve and enhance procedural consistency. Finally, adopt pricing frameworks that reflect total cost of care implications, enabling procurement teams to see the long-term value of device choices. Executing these recommendations will help organizations improve clinical adoption rates, reduce operational risk, and enhance the commercial durability of their product portfolios.

Robust mixed-methods research approach combining clinician insight, regulatory context, and supply chain analysis to support actionable conclusions

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to produce a holistic understanding of the hernia tacker landscape. Primary research encompassed structured interviews with surgeons, procurement leaders, and distribution partners to capture practical device performance considerations, adoption barriers, and training needs. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance, and publicly available procurement frameworks to contextualize clinical trends and policy influences.

Analytical methods included comparative device attribute mapping, supply chain sensitivity analysis, and segmentation-driven commercial modeling to evaluate how product characteristics align with different clinical settings and distribution channels. Triangulation across data sources ensured that conclusions reflect both frontline clinical experience and systemic market observations. Throughout the process, attention was paid to regulatory compliance, real-world usability, and the operational constraints that influence procurement decisions, yielding findings that are both actionable and grounded in contemporary practice.

Synthesis of clinical, commercial, and supply chain imperatives that define pathways to sustainable leadership in the hernia tacker market

In conclusion, the hernia tacker domain is at an inflection point where clinical practice evolution, material innovation, and commercial model reconfiguration converge. The device's trajectory will be determined by how effectively manufacturers respond to surgeon preferences, align materials and product types with clinical use cases, and invest in evidence that demonstrates tangible improvements in procedural efficiency and patient outcomes. Supply chain resilience and adaptive distribution strategies will also play critical roles, particularly in the face of trade policy shifts that affect material sourcing and cost dynamics.

Strategic success requires balancing near-term operational priorities with longer-term investments in clinical data and product differentiation. Organizations that integrate segmented market understanding with targeted regional strategies and close collaboration with surgical teams will be best positioned to convert technical capability into clinical adoption and sustainable commercial performance. This synthesis underscores the importance of deliberate, evidence-based decision-making for stakeholders seeking to lead in the hernia tacker space.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia Tacker Market, by Type

  • 8.1. Non-Absorbable Tackers
  • 8.2. Absorbable Tackers
  • 8.3. Disposable Tackers
  • 8.4. Reusable Tackers

9. Hernia Tacker Market, by Material Type

  • 9.1. Polymer
  • 9.2. Titanium

10. Hernia Tacker Market, by Product Type

  • 10.1. Disposable
  • 10.2. Reusable

11. Hernia Tacker Market, by Application

  • 11.1. Incisional Hernia
  • 11.2. Inguinal Hernia
  • 11.3. Umbilical Hernia
  • 11.4. Ventral Hernia

12. Hernia Tacker Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Hernia Tacker Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor

14. Hernia Tacker Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hernia Tacker Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hernia Tacker Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hernia Tacker Market

18. China Hernia Tacker Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Atrium Medical Corporation
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Cook Medical LLC
  • 19.9. Ethicon, Inc.
  • 19.10. Herniamesh S.r.l.
  • 19.11. LifeCell Corporation
  • 19.12. Medtronic plc
  • 19.13. Via Surgical Ltd.
  • 19.14. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA TACKER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA TACKER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA TACKER MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA TACKER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA TACKER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA TACKER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERNIA TACKER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERNIA TACKER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA TACKER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS HERNIA TACKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HERNIA TACKER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. G7 HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)